Chengdu Kanghua Biological Products Co., Ltd. (300841) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Chengdu Kanghua Biological Products Co., Ltd.

Why is Chengdu Kanghua Biological Products Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 9.68% and Operating profit at -3.53% over the last 5 years

Negative results in Mar 25

NET PROFIT(Q) At CNY 20.6 MM has Fallen at -86.17%
ROCE(HY) Lowest at 7.64%
INTEREST COVERAGE RATIO(Q) Lowest at 1,685.68

With ROE of 7.30%, it has a fair valuation with a 1.98 Price to Book Value

Over the past year, while the stock has generated a return of 23.97%, its profits have fallen by -59.1%
At the current price, the company has a high dividend yield of 1.3

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Chengdu Kanghua Biological Products Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Chengdu Kanghua Biological Products Co., Ltd.

38.75%

0.85

49.85%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

9.68%

EBIT Growth (5y)

-3.53%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.22

Sales to Capital Employed (avg)

0.40

Tax Ratio

14.30%

Dividend Payout Ratio

33.03%

Pledged Shares

Institutional Holding

ROCE (avg)

28.87%

ROE (avg)

16.97%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.98

EV to EBIT

21.93

EV to EBITDA

17.60

EV to Capital Employed

2.24

EV to Sales

5.22

PEG Ratio

Dividend Yield

1.35%

ROCE (Latest)

10.19%

ROE (Latest)

7.30%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by 1.75% (YoY

-36What is not working for the Company

NET PROFIT(Q)

At CNY 20.6 MM has Fallen at -86.17%

ROCE(HY)

Lowest at 7.64%

INTEREST COVERAGE RATIO(Q)

Lowest at 1,685.68

OPERATING PROFIT MARGIN(Q)

Lowest at 13.69 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.68%

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.96%

NET SALES(Q)

Lowest at CNY 137.41 MM

OPERATING PROFIT(Q)

Lowest at CNY 18.81 MM

PRE-TAX PROFIT(Q)

Lowest at CNY 19.95 MM

Here's what is working for Chengdu Kanghua Biological Products Co., Ltd.

Raw Material Cost

Fallen by 1.75% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Chengdu Kanghua Biological Products Co., Ltd.

Net Sales

At CNY 137.41 MM has Fallen at -55.67%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 19.95 MM has Fallen at -88.37%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 20.6 MM has Fallen at -86.17%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest Coverage Ratio

Lowest at 1,685.68

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit Margin

Lowest at 13.69 % and Fallen

In each period in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Net Sales

Lowest at CNY 137.41 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 18.81 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Pre-Tax Profit

Lowest at CNY 19.95 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 0.68%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 0.96%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio